Results 121 to 130 of about 21,736 (211)

Agentes dopaminérgicos e o tratamento da disfunção erétil

Química Nova, 2004
The understanding of the scientific basis of the erectile function expanded rapidly the range of therapies for treating erectile dysfunction in recent years.
Neves Gilda, Rates Stela M. K., Fraga Carlos A. M., Barreiro Eliezer J.   +3 more
doaj  

Effect of Dextromethorphan on Apomorphine induced licking behavior in rat

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2005
.
D Farzin, M Ali Nejad
doaj  

Efficacy and safety of apomorphine in the treatment of Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ther Adv Neurol Disord
Abouelmagd ME, Abbas A, Yousef O, Abdelrahman Hassan A, Kassar O, Sarhan K, Zakria Alnajjar A, Sabet H, Ahmed Zanaty M, Awad H, Kashbour M, Almuzghi F, Barrett MJ, Berman B, Negida A.   +14 more
europepmc   +1 more source

Therapeutic Spectrum of Intermittent Apomorphine in Parkinson's Disease: Neuropsychiatric, Behavioral, and Cognitive Analyses. [PDF]

Noro Psikiyatr Ars
Ünal ED.
europepmc   +1 more source

Hemihypomimia in Parkinson's disease [PDF]

, 2005
Brandt, T., Jahn, K., Strupp, M., Zingler, V. C.   +3 more
core   +1 more source

Nationwide analysis of real-world access to and use of device-aided therapies in Parkinson's disease: insights from the French National Healthcare Data System (2015-2021). [PDF]

BMJ Neurol Open
Auffret M, Nowak E, Vérin M, Kerbrat S.
europepmc   +1 more source

Extra-helical allosteric binding site of apomorphine in ADGRG6. [PDF]

Cell Discov
Qiu N, Xu W, Xu T, Xie W, Jiang Y, Zhong Z, Ma L, Zhao Q, Wu B, Han S.   +9 more
europepmc   +1 more source

Biochemical and nutritional changes during continuous subcutaneous apomorphine infusion in advanced Parkinson's disease: findings from an observational cohort. [PDF]

Ther Adv Neurol Disord
Phokaewvarangkul O, Rattanapitak N, Kuwattanasuchati P, Bhidayasiri R.   +3 more
europepmc   +1 more source

Mitochondrial DNA Damage in Substantia Nigra Pars Compacta Astrocytes Exacerbates Dopaminergic Neuron Loss in a 6-Hydroxydopamine Mouse Model of Parkinsonism. [PDF]

Cell Mol Neurobiol
Ayala DA, Hall GM, Das D, Tijerina E, Villagran LL, Khan Z, Paliwal D, Anand A, Rimer M, Srinivasan R.   +9 more
europepmc   +1 more source

Screening of FDA-Approved Small Molecules to Discover Inhibitors of the <i>Pseudomonas aeruginosa</i> Quorum-Sensing Enzyme, PqsE. [PDF]

Biochemistry
Jones HA, Baxter MJ, Zimmermann N, Li A, Perrault Uptmor KA, Taylor IR.   +5 more
europepmc   +1 more source